Cargando…

PDE5 inhibitors promote recovery of peripheral neuropathy in diabetic mice

Detalles Bibliográficos
Autores principales:	Wang, Lei, Chopp, Michael, Zhang, Zheng Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5361504/ https://www.ncbi.nlm.nih.gov/pubmed/28400802 http://dx.doi.org/10.4103/1673-5374.200804

Ejemplares similares

Tadalafil Promotes the Recovery of Peripheral Neuropathy in Type II Diabetic Mice
por: Wang, Lei, et al.
Publicado: (2016)

PDE5 inhibitor drugs for use in dementia
por: Hainsworth, Atticus H., et al.
Publicado: (2023)

Reactive astrocytes promote axonal remodeling and neurological recovery after stroke
por: Liu, Zhongwu, et al.
Publicado: (2014)

Sildenafil Ameliorates Long Term Peripheral Neuropathy in Type II Diabetic Mice
por: Wang, Lei, et al.
Publicado: (2015)

Therapeutic Benefit of Extended Thymosin β4 Treatment Is Independent of Blood Glucose Level in Mice with Diabetic Peripheral Neuropathy
por: Wang, Lei, et al.
Publicado: (2015)

MicroRNA-146a Mimics Reduce the Peripheral Neuropathy in Type 2 Diabetic Mice
por: Liu, Xian Shuang, et al.
Publicado: (2017)

Impact of gut-peripheral nervous system axis on the development of diabetic neuropathy
por: Mázala-de-Oliveira, Thalita, et al.
Publicado: (2023)

Early Detection of Diabetic Peripheral Neuropathy by fMRI: An Evidence-Based Review
por: Chitneni, Ahish, et al.
Publicado: (2022)

Exosome treatment for stroke with diabetic comorbidity
por: Venkat, Poornima, et al.
Publicado: (2021)

The efficacy of PDE5 inhibitors in diabetic patients
por: Swiecicka, Agnieszka
Publicado: (2022)

Influence of Sex on Cognition and Peripheral Neurovascular Function in Diabetic Mice
por: Fan, Baoyan, et al.
Publicado: (2018)

Cellular reprogramming and inherited peripheral neuropathies: perspectives and challenges
por: Saporta, Mario A.
Publicado: (2015)

Cell‐Based and Exosome Therapy in Diabetic Stroke
por: Venkat, Poornima, et al.
Publicado: (2018)

Emerging Roles of microRNAs as Biomarkers and Therapeutic Targets for Diabetic Neuropathy
por: Fan, Baoyan, et al.
Publicado: (2020)

Advances in diet-induced rodent models of metabolically acquired peripheral neuropathy
por: Eid, Stéphanie A., et al.
Publicado: (2021)

Targeting microthrombosis and neuroinflammation with vepoloxamer for therapeutic neuroprotection after traumatic brain injury
por: Xiong, Ye, et al.
Publicado: (2018)

Small extracellular vesicles ameliorate peripheral neuropathy and enhance chemotherapy of oxaliplatin on ovarian cancer
por: Zhang, Yi, et al.
Publicado: (2021)

Multifaceted roles of pericytes-interorgan interactions
por: Zheng, Zhitong, et al.
Publicado: (2020)

Reversal of neurobehavioral social deficits in dystrophic mice using inhibitors of phosphodiesterases PDE5A and PDE9A
por: Alexander, M S, et al.
Publicado: (2016)

Erythropoietin enhanced recovery after peripheral nerve injury
por: Modrak, Max, et al.
Publicado: (2017)

Central serous chorioretinopathy treatment with a systemic PDE5 and PDE6 inhibitor (sildenafil)
por: Coleman, D. Jackson, et al.
Publicado: (2020)

Challenges and opportunities identifying therapeutic targets for chemotherapy-induced peripheral neuropathy resulting from oxidative DNA damage
por: Kelley, Mark R., et al.
Publicado: (2017)

Investigation of PDE5/PDE6 and PDE5/PDE11 selective potent tadalafil-like PDE5 inhibitors using combination of molecular modeling approaches, molecular fingerprint-based virtual screening protocols and structure-based pharmacophore development
por: Kayık, Gülru, et al.
Publicado: (2017)

Extrinsic inhibitors in axon sprouting and functional recovery after spinal cord injury
por: Meves, Jessica M., et al.
Publicado: (2014)

PDE5 inhibitors enhance the lethality of [pemetrexed + sorafenib]
por: Booth, Laurence, et al.
Publicado: (2017)

Treatment Strategy for Non-Responders to PDE5 Inhibitors
por: Park, Nam Cheol, et al.
Publicado: (2013)

AB041. Evolution of PDE5 inhibitors in Korea
por: Moon, Du Geon
Publicado: (2015)

Sarm1 Gene Deficiency Attenuates Diabetic Peripheral Neuropathy in Mice
por: Cheng, Yalan, et al.
Publicado: (2019)

Promoting Generalized Learning in Balance Recovery Interventions
por: Harper, Sara A., et al.
Publicado: (2021)

Modulation of oxazolone-induced hypersensitivity in mice by selective PDE inhibitors
por: Moodley, I., et al.
Publicado: (1995)

Diabetic corneal neuropathy as a surrogate marker for diabetic peripheral neuropathy
por: So, Wei Zheng, et al.
Publicado: (2022)

Epigenetics in Stroke Recovery
por: Kassis, Haifa, et al.
Publicado: (2017)

Determination of Phosphodiesterase Type-5 Inhibitors (PDE-5) in Dietary Supplements
por: Gheorghiu, Oana Ramona Cătălina, et al.
Publicado: (2023)

Antispasmodic Drug Drofenine as an Inhibitor of Kv2.1 Channel Ameliorates Peripheral Neuropathy in Diabetic Mice
por: Xu, Xiaoju, et al.
Publicado: (2020)

SP6616 as a Kv2.1 inhibitor efficiently ameliorates peripheral neuropathy in diabetic mice
por: Zhu, Xialin, et al.
Publicado: (2020)

PDE5 Inhibitors as Potential Tools in the Treatment of Cystic Fibrosis
por: Noel, Sabrina, et al.
Publicado: (2012)

Using PDE5 inhibitors for the prevention and treatment of colorectal cancer
por: Browning, Darren D
Publicado: (2015)

Comparative dissolution study on counterfeit medicines of PDE-5 inhibitors
por: Deconinck, E., et al.
Publicado: (2014)

Computational Study on Selective PDE9 Inhibitors on PDE9-Mg/Mg, PDE9-Zn/Mg, and PDE9-Zn/Zn Systems
por: Sivakumar, Dakshinamurthy, et al.
Publicado: (2021)

Delayed peripheral treatment with neurotrophin-3 improves sensorimotor recovery after central nervous system injury
por: Kakanos, Sotiris G., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qr2s2ei2an700v7bjqe5qg5fdo